These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8929744)

  • 21. Refractory Kawasaki disease: infliximab or methotrexate therapy?
    Shin JI; Lee JS; Choi JY; Kim DS; Girish M; Subramaniam
    Indian J Pediatr; 2009 Nov; 76(11):1184; author reply 1184. PubMed ID: 20072867
    [No Abstract]   [Full Text] [Related]  

  • 22. Is cilostazol more effective than pentoxifylline in the treatment of symptoms of intermittent claudication?
    Weismantel D
    J Fam Pract; 2001 Feb; 50(2):181. PubMed ID: 11219570
    [No Abstract]   [Full Text] [Related]  

  • 23. [Advance in diagnosis and treatment of intravenous immunogolobulin-resistant Kawasaki disease].
    Zhang Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):318-21. PubMed ID: 19374823
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral Administration of Pentoxifylline Reduces Endometriosis-Like Lesions in a Nude Mouse Model.
    Perelló M; González-Foruria I; Castillo P; Martínez-Florensa M; Lozano F; Balasch J; Carmona F
    Reprod Sci; 2017 Jun; 24(6):911-918. PubMed ID: 27738175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of acute and refractory Kawasaki disease.
    Tacke CE; Burgner D; Kuipers IM; Kuijpers TW
    Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1203-15. PubMed ID: 23199405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of TNFalpha blockade in complicated, refractory Kawasaki disease.
    Stenbøg EV; Windelborg B; Hørlyck A; Herlin T
    Scand J Rheumatol; 2006; 35(4):318-21. PubMed ID: 16882598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness of pentoxifylline and of bio-electromagnetic therapy in lower limb obliterative arterial disease].
    Bernát SI
    Orv Hetil; 2013 Oct; 154(42):1674-9. PubMed ID: 24121220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms.
    Bahrmann P; Hengst UM; Richartz BM; Figulla HR
    Eur J Heart Fail; 2004 Mar; 6(2):195-201. PubMed ID: 14984727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of pentoxifylline on contrast induced nephropathy.
    Roozbeh J; Hamidian Jahromi A; Sharifian M; Pakfetrat M; Afshariani R
    Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):985-6. PubMed ID: 18974592
    [No Abstract]   [Full Text] [Related]  

  • 30. Severe ischemia of the glans penis following circumcision: a successful treatment via pentoxifylline.
    Aslan A; Karagüzel G; Melikoglu M
    Int J Urol; 2005 Jul; 12(7):705-7. PubMed ID: 16045570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pentoxifylline does not improve outcome in a murine model for the multiple-organ dysfunction syndrome.
    Volman TJ; Goris RJ; Hendriks T
    Intensive Care Med; 2005 May; 31(5):701-8. PubMed ID: 15711975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation.
    Cohen S; Tacke CE; Straver B; Meijer N; Kuipers IM; Kuijpers TW
    Ann Rheum Dis; 2012 Dec; 71(12):2059-61. PubMed ID: 22689319
    [No Abstract]   [Full Text] [Related]  

  • 33. Cerebral infarction after high-dose intravenous immunoglobulin therapy for Kawasaki disease.
    Wada Y; Kamei A; Fujii Y; Ishikawa K; Chida S
    J Pediatr; 2006 Mar; 148(3):399-400. PubMed ID: 16615977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized crossover study using yohimbine and isoxsuprine versus pentoxifylline in the management of vasculogenic impotence.
    Knoll LD; Benson RC; Bilhartz DL; Minich PJ; Furlow WL
    J Urol; 1996 Jan; 155(1):144-6. PubMed ID: 7490815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.
    Skudicky D; Bergemann A; Sliwa K; Candy G; Sareli P
    Circulation; 2001 Feb; 103(8):1083-8. PubMed ID: 11222470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose aspirin in Kawasaki disease.
    Shulman ST
    J Pediatr; 1999 Apr; 134(4):523-4. PubMed ID: 10190936
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study.
    Zeni F; Pain P; Vindimian M; Gay JP; Gery P; Bertrand M; Page Y; Page D; Vermesch R; Bertrand JC
    Crit Care Med; 1996 Feb; 24(2):207-14. PubMed ID: 8605790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compromised breast flap treated with leech therapy, hyperbaric oxygen, pentoxifylline and topical nitroglycerin: A case report.
    Moffat AD; Weaver LK; Tettelbach WH
    Undersea Hyperb Med; 2015; 42(3):281-4. PubMed ID: 26152110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pentoxifylline for treatment of venous leg ulcers: a systematic review.
    Jull A; Waters J; Arroll B
    Lancet; 2002 May; 359(9317):1550-4. PubMed ID: 12047963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistant Kawasaki disease treated with anti-CD20.
    Sauvaget E; Bonello B; David M; Chabrol B; Dubus JC; Bosdure E
    J Pediatr; 2012 May; 160(5):875-6. PubMed ID: 22341587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.